Clinical Trial Update: Study of XB010 in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating XB010 in locally advanced or metastatic solid tumors is currently recruiting across multiple indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Esophageal Squamous Cell Carcinoma
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• XB010

Snippet

Sponsor: Exelixis | Conditions: Locally Advanced or Metastatic Solid Tumors, Esophageal Squamous Cell Cancer | Phase 1 | Status: RECRUITING